NCT07669090

Brief Summary

Aim: This randomized controlled trial aimed to compare the effectiveness of virtual reality and progressive muscle relaxation exercise in reducing anxiety during the non-stress test (NST) and to evaluate their effects on maternal physiological parameters in high-risk pregnant women. Materials and Methods: The study was conducted as a randomized controlled trial between March 2025 and August 2025 at Kanuni Sultan Süleyman Training and Research Hospital with 126 high-risk pregnant women. Participants were randomly assigned to three groups (42 per group): virtual reality, progressive muscle relaxation exercise, and control group. During NST monitoring, participants in the virtual reality group received VR headset-based immersive audiovisual stimulation, while participants in the progressive muscle relaxation group performed guided relaxation exercises. The control group received routine NST monitoring without any additional intervention. Data were collected using the Informed Consent Form, Pregnant Woman Information Form, Non-Stress Test Follow-up Form, Physiological Parameters Follow-up Form, Visual Analog Scale (VAS), and State-Trait Anxiety Inventory (STAI Form TX-I). The STAI, VAS, and physiological parameters were measured before and after NST, while fetal NST parameters were recorded during the procedure.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
126

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2025

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2025

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

June 10, 2026

Completed
15 days until next milestone

First Posted

Study publicly available on registry

June 25, 2026

Completed
Last Updated

June 25, 2026

Status Verified

June 1, 2026

Enrollment Period

5 months

First QC Date

June 10, 2026

Last Update Submit

June 20, 2026

Conditions

Keywords

Virtual Reality, Anxiety, Progressive Relaxation Exercise, Non-Stress Test, Physiological Parameters, Pregnancy

Outcome Measures

Primary Outcomes (1)

  • Change in State-Trait Anxiety Inventory (STAI Form TX-I) Score Before and After the Non-Stress Test Procedure

    Maternal anxiety will be assessed using the State-Trait Anxiety Inventory (STAI Form TX-I). The change in anxiety score from immediately before the 20-minute non-stress test (NST) procedure to immediately after the procedure will be compared among the virtual reality, progressive muscle relaxation, and control groups.

    Immediately before and immediately after the 20-minute NST procedure.

Secondary Outcomes (10)

  • Change in Visual Analog Scale (VAS) Tension Score Before and After the Non-Stress Test Procedure

    Immediately before and immediately after the 20-minute NST procedure.

  • Change in Systolic Blood Pressure Before and After the Non-Stress Test Procedure

    Immediately before and immediately after the 20-minute NST procedure.

  • Change in Diastolic Blood Pressure Before and After the Non-Stress Test Procedure

    Immediately before and immediately after the 20-minute NST procedure.

  • Change in Maternal Pulse Rate Before and After the Non-Stress Test Procedure

    Immediately before and immediately after the 20-minute NST procedure.

  • Change in Respiratory Rate Before and After the Non-Stress Test Procedure

    Immediately before and immediately after the 20-minute NST procedure.

  • +5 more secondary outcomes

Study Arms (3)

Virtual Reality Group

EXPERIMENTAL

Participants will receive virtual reality relaxation exercises using VR glasses (Virtual reality intervention)

Behavioral: Virtual reality glasses

Progressive muscle relaxation exercises group

EXPERIMENTAL

Participants will receive progressive muscle relaxation exercises guided by audio instructions

Behavioral: Progressive muscle relaxation exercises

Control

NO INTERVENTION

Participants will receive routine care without any study-specific intervention

Interventions

The participants in the virtual reality (VR) group will be provided with a VR headset during non-stress test (NST) monitoring. They will be given the opportunity to choose one video from five available options according to their preference. The options will include nature-based audiovisual content such as natural scenery with ambient sounds, sea views with water sounds, and rain imagery with rainfall sounds. Each participant will watch the selected video during the NST. The audio level will be individually adjusted to ensure comfort and clear hearing. The adjustable VR headset, with a smartphone positioned at the front, will be properly fitted to each participant. The VR intervention will be applied for 20-30 minutes during the NST.

Also known as: Virtual reality
Virtual Reality Group

Participants in the progressive muscle relaxation (PMR) group will receive a guided PMR intervention during the non-stress test (NST), lasting 20-30 minutes. The intervention will be implemented by the researcher in accordance with the guidelines recommended on the website of the Cognitive Behavioral Therapies Association.

Also known as: Progressive muscle exercises
Progressive muscle relaxation exercises group

Eligibility Criteria

Age18 Years+
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsHigh risk pregnant woman
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Aged 18 years or older;
  • Able to read, write, and understand Turkish;
  • At ≥28 weeks of gestation;
  • Having a singleton pregnancy;
  • Having eaten, emptied the bladder, and refrained from smoking and alcohol consumption for at least 2 hours before the non-stress test (NST) procedure;
  • Diagnosed by a physician with a high-risk pregnancy, including but not limited to preeclampsia, gestational diabetes mellitus, gestational hypertension, chronic hypertension, type 1 or type 2 diabetes mellitus, decreased fetal movement, premature rupture of membranes, threatened preterm birth, intrauterine growth restriction (IUGR), small for gestational age (SGA), oligohydramnios, or polyhydramnios.

You may not qualify if:

  • Participants meeting any of the following criteria will be excluded:
  • Having a physical or mental condition that may impair communication;
  • Having a medical condition that may prevent participation in the intervention (e.g., musculoskeletal disorders, asthma);
  • Receiving magnesium sulfate (MgSO₄) treatment or having received MgSO₄ within the previous 2 hours.
  • Withdrawal Criteria
  • Participants will be withdrawn from the study if they:
  • Request to withdraw or no longer wish to continue participation in the study;
  • Are assigned to an intervention group and fail to participate in at least 80% of the intervention sessions.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kanuni Sultan Suleyman Training and Research Hospital

Istanbul, Turkey (Türkiye)

Location

Related Publications (2)

  • Aksoy, Y. E., Yılmaz, S. D., & Kılıç, S. (2024). *International Journal of Nursing Practice*.

    BACKGROUND
  • Dominguez-Solis E, Lima-Serrano M, Lima-Rodriguez JS. Non-pharmacological interventions to reduce anxiety in pregnancy, labour and postpartum: A systematic review. Midwifery. 2021 Nov;102:103126. doi: 10.1016/j.midw.2021.103126. Epub 2021 Aug 14.

    PMID: 34464836BACKGROUND

Related Links

MeSH Terms

Conditions

Anxiety Disorders

Condition Hierarchy (Ancestors)

Mental Disorders

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator, Midwife

Study Record Dates

First Submitted

June 10, 2026

First Posted

June 25, 2026

Study Start

March 1, 2025

Primary Completion

August 1, 2025

Study Completion

August 1, 2025

Last Updated

June 25, 2026

Record last verified: 2026-06

Data Sharing

IPD Sharing
Will not share

Will not be disclosed for confidentiality reasons.

Locations